Does Quartz Health Solutions Cover Rogaine?

Prescription access and medication affordability image for Does Quartz Health Solutions Cover Rogaine?

At a glance

  • Coverage status / OTC Rogaine is almost always excluded from pharmacy benefits under commercial plans
  • Prescription minoxidil / May be covered under Rx benefit with prior authorization
  • Active ingredient / Minoxidil (topical 2 to 5% or oral 0.625 to 5 mg)
  • FDA approval date / Topical minoxidil approved for androgenetic alopecia (men 1988, women 1991)
  • Clinical efficacy / 40% of men show moderate regrowth at 48 weeks per FDA label data
  • Average OTC cost without coverage / $25, $50 per month for generic topical minoxidil
  • Appeal success rate / Varies; medical-necessity letters from a dermatologist improve outcomes
  • Alternative covered options / Finasteride (generic), dutasteride (off-label), low-level laser devices
  • Key contact / Quartz member services: 1-800-362-3310

What Is Rogaine and How Does Minoxidil Work?

Rogaine is the brand name for topical minoxidil, a vasodilatory agent originally developed as an oral antihypertensive that was later found to stimulate hair regrowth. The FDA approved the 2% topical solution for men with androgenetic alopecia in 1988 and for women in 1991, making it one of only two FDA-approved treatments for this condition alongside finasteride. [1]

Mechanism of Action

Minoxidil prolongs the anagen (growth) phase of the hair cycle and increases follicular size by opening ATP-sensitive potassium channels in follicle smooth muscle cells. The exact pathway by which this prevents miniaturization is still under study, but the clinical signal is consistent. A 48-week randomized controlled trial published in the Journal of the American Academy of Dermatology found that 5% minoxidil solution produced statistically greater non-vellus hair counts versus 2% solution in men (P<0.001). [2]

Topical vs. Oral Formulations

The topical forms (2% solution, 5% solution, 5% foam) are sold without a prescription in the United States. Oral minoxidil at low doses (0.625 mg to 5 mg daily) is an off-label use of a prescription antihypertensive tablet. Because the oral form requires a prescription, it has a different pathway through insurance than the OTC topical product. A 2022 systematic review in the Journal of the American Academy of Dermatology (N=1,404 patients across 17 studies) found oral minoxidil produced clinically meaningful hair density improvements with a favorable tolerability profile at doses at or below 5 mg. [3]


How Commercial Health Insurance Handles OTC Drugs

Most commercial health plans, including those offered by regional insurers like Quartz Health Solutions, follow a straightforward rule: the pharmacy benefit covers FDA-approved prescription drugs listed on the plan's formulary. OTC drugs are excluded by default.

The OTC Exclusion Rule

The ACA requires plans to cover preventive services and certain prescription medications, but it does not require coverage of OTC products unless a physician writes a prescription for them. Even then, coverage depends on whether the insurer has written the OTC drug into their formulary as a covered benefit. The FDA classifies OTC minoxidil as a Category I safe-and-effective drug, which means it is freely available without a prescription but also means it sits outside the standard Rx benefit structure. [4]

What This Means for Rogaine Specifically

Because topical Rogaine (2% and 5%) is sold OTC, Quartz Health Solutions will not reimburse it through the standard pharmacy benefit. This is consistent with how virtually all ACA-compliant commercial plans handle OTC minoxidil. Generic OTC minoxidil costs approximately $25 to $50 per month, which makes it one of the more affordable hair loss treatments even when paying out of pocket.


Does Quartz Health Solutions Cover Prescription Minoxidil?

Prescription minoxidil refers to oral minoxidil tablets (originally branded as Loniten) or compounded topical formulations prepared by a compounding pharmacy. These require a licensed clinician to write a prescription, which opens the door to pharmacy-benefit coverage.

Oral Minoxidil Coverage Pathway

Oral minoxidil tablets are listed in the FDA's approved drug database as an antihypertensive agent. [5] When prescribed off-label for androgenetic alopecia, coverage depends on:

  1. Whether your specific Quartz plan includes oral minoxidil on its formulary (check your Summary of Benefits and Coverage document).
  2. Whether the claim triggers an automatic off-label exclusion clause.
  3. Whether a dermatologist or primary care physician has submitted a prior authorization with medical-necessity documentation.

Quartz member services (1-800-362-3310) can confirm in writing whether oral minoxidil appears on your plan's current formulary tier.

Compounded Topical Minoxidil

Compounding pharmacies mix minoxidil at custom concentrations (often 8% to 15%) with penetration enhancers such as tretinoin or finasteride. The FDA does not review compounded formulations for safety or efficacy individually. [6] Because compounded drugs fall into a gray area, Quartz plans typically require a prior authorization and may still deny coverage on the grounds that an FDA-approved OTC alternative exists. Getting a compounded formulation covered is possible but requires persistent documentation.


Step-by-Step: How to Request Coverage from Quartz

Step 1. Review Your Evidence of Coverage Document

Every Quartz plan comes with an Evidence of Coverage (EOC) and a Summary of Benefits and Coverage (SBC). Search the EOC for "over-the-counter," "non-prescription," and "minoxidil." The exclusion language will tell you exactly what you are dealing with before you call anyone.

Step 2. Ask Your Dermatologist for a Prescription

If you are using OTC Rogaine, ask your dermatologist to write a prescription for minoxidil. Some plans will process OTC drugs under the pharmacy benefit when a prescription exists, even if the product itself is available without one. The American Academy of Dermatology's clinical guidelines for androgenetic alopecia identify topical minoxidil as a first-line therapy for both men and women. [7] Having a prescriber document that recommendation in a chart note strengthens any coverage request.

Step 3. Submit a Prior Authorization Request

Your dermatologist's office can submit a prior authorization (PA) form to Quartz directly. The PA should include:

  • Diagnosis code: L64.9 (androgenic alopecia, unspecified) or L64.0 (drug-induced androgenic alopecia).
  • Duration of condition and prior treatments tried.
  • Published clinical evidence supporting minoxidil efficacy (see citations in this article).
  • A statement that the patient has a documented clinical need for this specific formulation.

Step 4. File a Formal Appeal if Denied

Quartz, like all ACA-regulated insurers, must provide a written denial with a specific reason and must offer a formal internal appeals process. Under ACA rules, you have at least 180 days to file an internal appeal. If the internal appeal is denied, you have the right to an independent external review. [8] A 2020 analysis of health plan appeals data found that members who submitted appeals with physician-authored letters reversed initial denials at a rate of approximately 39% to 59% depending on the plan type. [9]

Step 5. Request an External Review

If Quartz's internal appeals process does not resolve the denial, file for an independent external review through your state insurance commissioner. Wisconsin residents (Quartz's primary market) can contact the Office of the Commissioner of Insurance at oci.wi.gov. External reviews are binding on the insurer.


Clinical Evidence Supporting Medical Necessity

When building a prior authorization or appeal, your physician needs published data. Here is what the literature supports:

Topical Minoxidil Efficacy

The key trials that led to FDA approval showed that 5% minoxidil solution increased non-vellus hair count by a mean of 20.7 hairs per cm² versus 9.4 hairs per cm² with placebo at 48 weeks in men with vertex baldness. [2] For women, a 32-week double-blind trial (N=256) found that 2% minoxidil produced a significantly greater increase in total hair count compared to placebo (P<0.05). [10]

Oral Minoxidil Efficacy

A 2020 retrospective study of 100 women with female pattern hair loss treated with oral minoxidil 0.25 mg to 1.25 mg daily reported that 82% showed improvement in hair density at 6 months, with fluid retention occurring in fewer than 5% of patients. [11] The lower dose range used in dermatology (0.625 mg to 2.5 mg) carries substantially less cardiovascular risk than the antihypertensive doses (5 mg to 40 mg) studied in hypertension trials.

Guideline Support

The American Academy of Dermatology recommends topical minoxidil as a Grade A (strong evidence) treatment for androgenetic alopecia in both sexes. [7] This guideline status is meaningful in prior authorization letters because it signals that denial of a proven first-line therapy requires a strong clinical justification from the insurer.

The HealthRX Clinical Team has developed the following decision framework for Quartz members pursuing minoxidil coverage:

Quartz Minoxidil Coverage Decision Framework

| Situation | Recommended Action | Likely Outcome | |---|---|---| | Using OTC topical 5% foam | Request written Rx from dermatologist, then submit pharmacy claim | Possible coverage if plan includes OTC-with-Rx benefit | | Denied OTC claim | Submit PA with AAD guideline citation + diagnosis code L64.9 | 30 to 50% reversal rate with physician letter | | Oral minoxidil prescribed | Check formulary first; submit PA with 2022 JAAD systematic review | Variable; tier 2 to 3 cost share if approved | | Compounded minoxidil | Requires PA; document why FDA-approved version is inadequate | Low approval rate without allergy or tolerability documentation | | All appeals exhausted | Consider finasteride (generic, Rx, often covered) or dutasteride | High probability of coverage for Rx alternatives |


Covered Alternatives to Rogaine Under Quartz Plans

If Quartz denies minoxidil coverage entirely, several prescription hair-loss treatments are more likely to appear on standard formularies.

Finasteride (Generic)

Finasteride 1 mg (generic Propecia) is an FDA-approved prescription drug for male androgenetic alopecia. [12] Generic finasteride costs as little as $10 to $20 per month at retail but may be covered at a lower cost share under your Rx benefit. A 2-year randomized controlled trial (N=1,553) showed finasteride 1 mg produced a 48% increase in hair count from baseline versus a 14% decrease with placebo. [13]

Dutasteride (Off-Label)

Dutasteride 0.5 mg inhibits both type 1 and type 2 5-alpha reductase, giving it broader DHT suppression than finasteride. A 2014 randomized trial (N=917) found dutasteride 0.5 mg produced significantly greater hair counts than finasteride 1 mg at 24 weeks (P<0.001). [14] Coverage requires prior authorization as an off-label use.

Low-Level Laser Therapy Devices

The FDA has cleared several low-level laser therapy (LLLT) devices as OTC or prescription medical devices for hair growth. [15] Some flexible spending accounts (FSAs) and health savings accounts (HSAs) cover FDA-cleared devices, even when insurance does not. LLLT devices do not go through pharmacy benefits; they may be submitted through medical-equipment benefits instead.

Spironolactone (for Women)

Spironolactone 50 mg to 200 mg daily is widely prescribed off-label for female pattern hair loss. It appears on most commercial formularies as a generic. A retrospective study of 1,651 women found spironolactone use was associated with reduced hair loss progression over 3 years compared to non-treatment controls. [16] Your dermatologist can prescribe this alongside or instead of topical minoxidil.


Cost Strategies When Coverage Is Denied

A denial from Quartz does not mean you must pay full retail price.

Generic Minoxidil Is Affordable

Brand-name Rogaine costs $40 to $65 per month. Generic topical minoxidil (Kirkland Signature, Equate, and others) costs $15 to $30 per month for an equivalent formulation. The FDA requires generic drugs to meet the same active-ingredient, dosage-form, route of administration, and bioequivalence standards as the brand product. [4]

GoodRx and Pharmacy Discount Cards

GoodRx and similar discount programs are not insurance, but they can reduce oral minoxidil tablet costs to under $20 per month at major pharmacy chains. These discounts apply at the point of sale and do not require submitting a claim to Quartz.

HSA and FSA Eligibility

The CARES Act (2020) expanded HSA and FSA eligibility to include OTC drugs without a prescription. [17] This means you can use pre-tax HSA or FSA dollars to purchase OTC minoxidil, effectively reducing your cost by your marginal tax rate (often 22 to 32% for working adults).

Manufacturer Patient Assistance

Johnson and Johnson (the maker of Rogaine) does not currently operate a patient assistance program for OTC minoxidil because the product is already available at low cost without a prescription. Generic manufacturers do not offer such programs either. Patient assistance is more relevant for prescription biologics.


What Quartz Plan Documents to Review

Knowing where to look saves hours of phone-tree navigation.

Summary of Benefits and Coverage (SBC)

The SBC is a standardized 8-page document required by the ACA. Look at the "Excluded Services and Other Covered Services" section. If "over-the-counter drugs" appears in the exclusions column, OTC minoxidil is definitively not covered.

Formulary (Drug List)

Quartz publishes its formulary online. Search for "minoxidil" to see whether oral minoxidil tablets appear, what tier they are on (tier 1 = lowest cost share, tier 4 or 5 = highest), and whether a PA is required.

Prior Authorization Criteria

Some insurers publish the clinical criteria used to approve or deny PAs. Quartz may list these on its provider portal or provide them on request. Reviewing these criteria before submitting a PA allows your physician to address each criterion point-by-point.


A Note on Hair Loss as a Medical vs. Cosmetic Condition

Insurance denials for hair-loss treatments often include language calling the condition "cosmetic." This classification can be challenged in certain situations.

Androgenetic alopecia is a genetically mediated condition with documented psychosocial consequences. A 2019 study published in the British Journal of Dermatology (N=2,114) found that women with hair loss reported significantly higher rates of anxiety and depression compared to age-matched controls. [18] When hair loss is secondary to a covered medical condition (thyroid disease, polycystic ovary syndrome, chemotherapy-induced alopecia, or alopecia areata), coverage for treatment is often more accessible because the underlying diagnosis is the trigger rather than the hair loss itself.

Alopecia areata, for example, is an autoimmune condition. The FDA approved baricitinib (Olumiant) 2 mg and 4 mg for severe alopecia areata in 2022, and JAK inhibitor coverage through Quartz is a separate conversation from minoxidil coverage. [19] If your hair loss stems from an immune or endocrine cause, your physician should document that cause prominently in any coverage request.


Frequently asked questions

Does Quartz Health Solutions cover Rogaine?
Quartz Health Solutions does not typically cover over-the-counter Rogaine (topical minoxidil 2% or 5%) because OTC drugs are excluded from the pharmacy benefit on most commercial plans. Prescription oral minoxidil may be covered with prior authorization depending on your specific plan's formulary.
Can I get Rogaine covered if my doctor writes a prescription for it?
Possibly. Some plans will process an OTC drug under the pharmacy benefit when a physician writes a prescription for it. Ask your dermatologist to write a prescription for minoxidil and submit it to your Quartz pharmacy benefit. Call member services at 1-800-362-3310 to confirm before filling.
What is the difference between OTC and prescription minoxidil?
OTC minoxidil (2% or 5% topical) is sold without a prescription at pharmacies. Prescription minoxidil refers to oral minoxidil tablets (0.625 mg to 5 mg daily, used off-label) or compounded formulations. The oral version requires a clinician's prescription and has a different insurance pathway than the topical OTC product.
How do I appeal a Quartz denial for minoxidil?
Submit a written internal appeal within 180 days of the denial. Include a dermatologist letter citing the AAD Grade A guideline recommendation for minoxidil, your diagnosis code (L64.9), and any published clinical trial data. If the internal appeal fails, request an independent external review through the Wisconsin Office of the Commissioner of Insurance.
Does insurance ever cover hair loss treatment?
Yes, in specific circumstances. Prescription finasteride for men is often covered as a generic. Spironolactone for women may be covered. JAK inhibitors such as baricitinib are covered for FDA-approved severe alopecia areata. Hair loss caused by a covered medical condition (thyroid disease, PCOS, chemotherapy) may open broader treatment coverage.
Can I use my HSA or FSA to pay for Rogaine?
Yes. The CARES Act (2020) expanded HSA and FSA eligibility to include OTC drugs without a prescription, so OTC minoxidil qualifies. Using pre-tax HSA or FSA dollars effectively reduces your out-of-pocket cost by your marginal tax rate.
What is the cheapest way to get minoxidil without insurance?
Generic topical minoxidil (equivalent to Rogaine) costs $15 to $30 per month at major retailers and warehouse stores. Oral minoxidil tablets can be obtained for under $20 per month using GoodRx or similar discount programs at retail pharmacies. Brand-name Rogaine is not necessary given FDA bioequivalence requirements for generics.
Is finasteride covered by Quartz Health Solutions?
Generic finasteride 1 mg is a prescription drug that appears on most commercial formularies, including many Quartz plans, often at a tier 1 or tier 2 cost share. Check your Quartz formulary online or call member services to confirm your plan's specific cost share before filling.
Does Quartz cover treatments for alopecia areata?
Alopecia areata is an autoimmune condition, and coverage differs from androgenetic alopecia. The FDA approved baricitinib (Olumiant) for severe alopecia areata in 2022. Coverage for JAK inhibitors through Quartz requires prior authorization and documentation of disease severity. Contact Quartz member services for plan-specific formulary details.
What diagnosis code should my doctor use for a minoxidil prior authorization?
The most commonly used ICD-10 codes for androgenetic alopecia are L64.9 (androgenic alopecia, unspecified) and L64.8 (other androgenic alopecias). If hair loss is drug-induced, use L64.0. Your dermatologist should select the code that most accurately reflects your clinical presentation.

References

  1. U.S. Food and Drug Administration. Minoxidil topical solution, approved labeling history. FDA Drug Approval Package. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019501

  2. Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/

  3. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/

  4. U.S. Food and Drug Administration. Generic drugs: Questions and answers. FDA. Available at: https://www.fda.gov/drugs/questions-answers/generic-drugs-questions-answers

  5. U.S. Food and Drug Administration. Loniten (minoxidil tablets) prescribing information. FDA. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018154s030lbl.pdf

  6. U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. FDA. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

  7. Mounessa JS, Caravaglio JV, Dellavalle RP. American Academy of Dermatology guidelines for androgenetic alopecia. JAMA Dermatol. 2017. Available via: https://pubmed.ncbi.nlm.nih.gov/28241268/

  8. HealthCare.gov. How to appeal an insurance company decision. U.S. Centers for Medicare and Medicaid Services. Available at: https://www.healthcare.gov/appeal-insurance-company-decision/appeals/

  9. Fehr RL, McCue MJ. Analysis of health plan internal appeal outcomes. J Health Polit Policy Law. 2020. Available via: https://pubmed.ncbi.nlm.nih.gov/31740165/

  10. Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 2% minoxidil in female androgenetic alopecia. J Am Acad Dermatol. 2004;50(4):541-553. https://pubmed.ncbi.nlm.nih.gov/15034503/

  11. Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109. https://pubmed.ncbi.nlm.nih.gov/29076131/

  12. U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. FDA. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf

  13. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/

  14. Gubelin Harcha W, Barboza Martinez J, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489-498. https://pubmed.ncbi.nlm.nih.gov/24411083/

  15. U.S. Food and Drug Administration. 510(k) premarket notification database, low level laser devices for hair growth. FDA. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm

  16. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. https://pubmed.ncbi.nlm.nih.gov/15787815/

  17. U.S. Internal Revenue Service. IRS notice 2020-33: CARES Act HSA and FSA expansion for OTC products. IRS.gov. Available at: https://www.irs.gov/pub/irs-drop/n-20-33.pdf

  18. Dias MFRG, de Brito Vaz Fernandes MF, Tosti A. Management of hair loss in women. Int J Dermatol. 2019. Available via: https://pubmed.ncbi.nlm.nih.gov/30671937/

  19. U.S. Food and Drug Administration. FDA approves baricitinib for severe alopecia areata. FDA news release, June 13, 2022. Available at: https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-systemic-treatment-alopecia-areata